ABP News on MSN
US FDA approves new hepatitis B treatment: Can patients finally stop taking antivirals?
The US Food and Drug Administration (FDA) has approved a new treatment for adults with chronic hepatitis B, offering some ...
GINATILAN’S African swine fever (ASF) outbreak is now considered contained after all 60 blood samples taken from pigs in the ...
In its own approval announcement on Oct. 20, the FDA hailed Hibsago as a “first-of-its-kind” treatment in chronic hepatitis B ...
Health and Me on MSN
US FDA approves first-of-its-kind hepatitis B drug that helped 19% patients stay off treatment for six months
The US FDA recently approved Hibsago (bepirovirsen), a new drug for chronic hepatitis B that could help control viral ...
Mens Fitness on MSN
FDA Approves Hibsago, a Hepatitis B Treatment That Could Let Some Patients Stop Therapy
FDA-approved Hibsago could help some adults with chronic hepatitis B stop antiviral therapy. Learn who qualifies, what trials found, and the key risks.
Hibsago’s approval—a functional cure for certain patients with a hepatitis B infection—further validates Ionis ...
The Kearney Area Animal Shelter recently received a positive result of Streptococcus equi subspecies zooepidemicus as part of ...
US Approves New Hepatitis B Treatment, Offers Hope to Patients - The United States has approved a new treatment for chronic ...
The FDA also authorized the Roche Elecsys HBsAg II quant II RxDx assay as a companion diagnostic device to aid in the ...
"A big part of ‘think, believe, know’ is data collection. Data especially drives our variable-rate efforts. From seed to ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results